Latest Breaking News On - Res clin - Page 2 : comparemela.com

Glenmark is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India

Glenmark is the first to launch Biosimilar of Popular Anti-Diabetic Drug, Liraglutide, in India
bignewsnetwork.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bignewsnetwork.com Daily Mail and Mail on Sunday newspapers.

United statesPioglitazone zita pioLiraglutide lirafitAlok malikSitagliptin sitazitRemogliflozin remoDapagliflozin zitaGlenmark pharmaceuticals limitedAmerican diabetes associationConsensus statement european society of cardiologyGlenmark pharmaceuticals ltdAmerican diabetes association professional practice committeeEuropean unionScientific document groupSteering committeeBiosimilars companies

1 in 2 diabetics suffer from Peripheral Neuropathy during their lifetime

1 in 2 diabetics suffer from Peripheral Neuropathy during their lifetime
inquirer.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.net Daily Mail and Mail on Sunday newspapers.

Minga cunananAsia pacificInternational diabetes federationNerve healthEpg healthPg health philippinesPg health knowthesigns campaignWorld diabetes dayPeripheral neuropathyMake life sweeterNerve damageVitaminb deficiencyGeneral managerMiddle eastSoutheast asiaCollective action

Stress hyperglycemia leads to worse outcomes in patients with acute type A aortic dissection

China: A recent study has shown that about 40% of the patients with acute type A aortic dissection (ATAAD) have stress-induced hyperglycemia (SIH) and were at higher risk to receive non-surgical.

Kefei douChinese academy of medical sciencesUnion medical collegeChinese academyMedical sciencesPeking union medical collegeRes clinDiabetes research and clinical practiceCute typea aortic dissectionTress hyperglycemiaBlood glucoseBlood sugar

Insulin Sensitizers May Be Making a Comeback

Researchers have identified new uses for insulin sensitizers, including in the treatment of polycystic ovary syndrome and infertility.

Shivaswamyv pioglitazoneCardiovasc diabetolJialali thiazolidinedionesStudy groupVasc health risk managTakeda pharmaceuticalsBristol myers squibb companySyda productionsMyers squibb companyRes clinClin endocrinolProc natl acad sci unitedMayo clinVasc health riskUpdated februaryDiabetes obes

Cost Analysis of Self-Monitoring Blood Glucose in Nonintensively Managed Type 2 Diabetes

Analysis of claims data showed reduced utilization and costs among patients with nonintensively treated type 2 diabetes (T2D) using self-monitoring of blood glucose compared with continuous glucose monitoring.

United statesSwitzerland generalEli lillySanta claraSanta barbaraDavid kerrDiabetes technology societyDepartment of precisionNovo nordiskAmerican diabetes associationUs bureau of labor statisticsRoche diagnostics international ltdHealth careAmerican diabetes association standards of careCoalition for clinical researchD international classification of diseases